Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Comisso

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Transplantation Proceedings|November 13, 2019
Early Aspirin Nonresponders Identification by Routine Use of Aggregometry Test in Patients With Left Ventricle Assist Devices Reduces the Risk of Pump ThrombosisA Montalto, M Comisso, A Cammardella, et al.
Experimental Hematology|April 1, 1995
The hematon, a morphogenetic functional complex in mammalian bone marrow, involves erythroblastic islands and granulocytic cobblestonesI Blazsek, X H Liu, A Anjo, et al.
Leukemia Research|January 1, 1985
In vitro induction of CFU-S proliferation by a non viral splenic activity from myeloproliferative sarcoma virus infected miceM C Le Bousse-Kerdiles, F Smadja-Joffe, A M Bertoli, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1995
Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cellsX H Liu, I Blazsek, M Comisso, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
Excess of lympho-reticular cell complexes in the bone marrow linked to T cell mediated dysmyelopoiesisI Blazsek, E Goldschmidt, D Machover, et al.
Clinical Pharmacology and Therapeutics|August 1, 1994
Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: relationship with mucosal toxicity in patients with cancerG Metzger, C Massari, M C Etienne, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemiaI Blazsek, C Farabos, M Musset, et al.
Cancer Detection and Prevention|January 1, 1992
Combined differentiation therapy in myelodysplastic syndrome with retinoid acid, 1 alpha,25 dihydroxyvitamin D3, and prednisoneI Blazsek, M Musset, D Boulé, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Transplantation Proceedings|November 13, 2019
Early Aspirin Nonresponders Identification by Routine Use of Aggregometry Test in Patients With Left Ventricle Assist Devices Reduces the Risk of Pump ThrombosisA Montalto, M Comisso, A Cammardella, et al.
Experimental Hematology|April 1, 1995
The hematon, a morphogenetic functional complex in mammalian bone marrow, involves erythroblastic islands and granulocytic cobblestonesI Blazsek, X H Liu, A Anjo, et al.
Leukemia Research|January 1, 1985
In vitro induction of CFU-S proliferation by a non viral splenic activity from myeloproliferative sarcoma virus infected miceM C Le Bousse-Kerdiles, F Smadja-Joffe, A M Bertoli, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1995
Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cellsX H Liu, I Blazsek, M Comisso, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
Excess of lympho-reticular cell complexes in the bone marrow linked to T cell mediated dysmyelopoiesisI Blazsek, E Goldschmidt, D Machover, et al.
Clinical Pharmacology and Therapeutics|August 1, 1994
Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: relationship with mucosal toxicity in patients with cancerG Metzger, C Massari, M C Etienne, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemiaI Blazsek, C Farabos, M Musset, et al.
Cancer Detection and Prevention|January 1, 1992
Combined differentiation therapy in myelodysplastic syndrome with retinoid acid, 1 alpha,25 dihydroxyvitamin D3, and prednisoneI Blazsek, M Musset, D Boulé, et al.
Pageof 2